Results 281 to 290 of about 320,412 (378)

ASYMPTOMATIC HYPONATREMIA IN PULMONARY TUBERCULOSIS 1 [PDF]

, 1950
Ethan A.H. Sims, Louis G. Welt, Jack Orloff, James W. Needham   +3 more
openalex   +1 more source

Connective tissue disease‐associated interstitial lung disease: an approach to treatment amidst an expanding evidence base

Internal Medicine Journal, EarlyView.
ABSTRACT Connective tissue disease‐associated interstitial lung disease (CTD‐ILD) comprises a heterogenous group of conditions characterised by immune‐mediated fibro‐inflammatory pulmonary injury. Although the disease course is variable, CTD‐ILD can progress to respiratory failure and thus has a profound impact on morbidity and mortality.
Michael Hong, Elizabeth Veitch, Sandhya Limaye   +2 more
wiley   +1 more source

Clustering and risk factor analysis of pulmonary tuberculosis in a district in Ethiopia: a population-based cohort study. [PDF]

BMJ Open
Banti AB, Datiko DG, Winje BA, Hinderaker SG, Heldal E, Dangisso MH.   +5 more
europepmc   +1 more source

A Further Report on Lung Resection for Pulmonary Tuberculosis [PDF]

, 1952
B. J. Bickford, Fred Edwards, J. R. Esplen, Joseph Gifford, O. F. Thomas   +4 more
openalex   +1 more source

Human Alveolar Macrophages Detect SARS‐CoV‐2 Envelope Protein Through TLR2 and TLR4 and Secrete Cytokines in Response

Immunology, EarlyView.
Alveolar macrophages (AMs)—the most numerous immune cells of the lung—respond to viral infections by secreting cytokines to summon other immune cells. We investigated whether AMs recognize SARS‐CoV‐2 proteins and how they respond. AMs did not sense spike protein but did recognize envelope protein via the pattern recognition receptors TLR2 and TLR4 ...
Conor Grant, Emily Duffin, Finbarr O’Connell, Parthiban Nadarajan, Colm Bergin, Joseph Keane, Mary P. O'Sullivan   +6 more
wiley   +1 more source

Association Between Pulmonary Tuberculosis and Bronchial Anthracosis. [PDF]

Cureus
Ahmed K, Sumalani KK, Akhter N, Ahmed M, Baqi A, Rizvi N.   +5 more
europepmc   +1 more source

PULMONARY RESECTION IN TUBERCULOSIS

, 1952
Joseph W. Gale, Helen A. Dickie, Anthony R. Curreri   +2 more
openalex   +2 more sources

Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
ALLEGRO‐LT (NCT04006457) is an open‐label, phase 3 study investigating the long‐term safety and efficacy of ritlecitinib in patients with alopecia areata (AA). In this analysis in 449 de novo patients with AA and ≥25% scalp hair loss, ritlecitinib demonstrated clinical efficacy and had an acceptable safety profile through Month 24.
C. Tziotzios, R. Sinclair, A. Lesiak, S. Mehlis, M. Kinoshita‐Ise, A. Tsianakas, X. Luo, E. H. Law, R. Ishowo‐Adejumo, R. Wolk, M. Sadrarhami, A. Lejeune   +11 more
wiley   +1 more source

Clinical Characteristics of Miliary Pulmonary Tuberculosis in Pregnancy After In Vitro Fertilization-Embryo Transfer: A Retrospective Clinical Study. [PDF]

Health Sci Rep
Guo L, Wu X, Cao L.
europepmc   +1 more source

European Guideline (EuroGuiDerm) on atopic eczema: Living update

Journal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg, M. Kinberger, B. Arents, N. Aszodi, S. Barbarot, T. Bieber, H. A. Brough, P. Calzavara‐Pinton, S. Christen‐Zaech, M. Deleuran, M. Dittmann, N. Fosse, K. Gáspár, L. A. A. Gerbens, U. Gieler, G. Girolomoni, S. Gregoriou, S. Holland, C. G. Mortz, A. Nast, U. Nygaard, E. M. Rehbinder, J. Ring, M. Rossi, E. Serra‐Baldrich, D. Simon, Z. Z. Szalai, J. C. Szepietowski, A. Torrelo, T. Werfel, R. N. Werner, C. Flohr   +31 more
wiley   +1 more source